|
|
||||||||
Eur J Cardiothorac Surg 2004;26:73-80
© 2004 Elsevier Science NL
a Division of Thoracic and Cardiovascular Surgery, Hannover Medical School, Carl-Neuberg-Strasse, D-30625 Hannover, Germany
b Department of Anaesthesiology, Hannover Medical School, Hannover, Germany
Received 18 January 2004; received in revised form 2 April 2004; accepted 5 April 2004.
* Corresponding author. Tel.: +49-511-532-6581; fax: +49-511-532-5404
e-mail: hagl{at}thg.mh-hannover.de
| Abstract |
|---|
|
|
|---|
Key Words: Aortic surgery Hypothermic circulatory arrest Selective antegrade cerebral perfusion Cerebral protection Pig model
| 1. Introduction |
|---|
|
|
|---|
On the basis, that clinical as well as experimental data on the value of retrograde cerebral perfusion (RCP) techniques are still a matter of controversial discussion [2,3], selective antegrade cerebral perfusion (SACP) methods became increasingly popular. Recent reports from clinical studies clearly demonstrate a favourable outcome [4,5] in those patients, but prospective controlled studies are still missing. Reviewing data from the literature, there are a number of technical details how SACP can be used [3]. These techniques include different cannulation techniques, variable levels of general hypothermia and diverse protocols regarding antegrade flow and temperature. From the recently published data it is not possible to decide which technique may offer the best protection for the organ most sensitive to ischemiathe brain. Furthermore, most techniques are based on empiric findings, since experimental datarelying on pathophysiological findingsare limited.
In the past, the Mount Sinai group affiliated with Randall Griepp established a clinically relevant porcine model which allowed a deeper insight into the cerebral consequences of hypothermic circulatory arrest, RCP as well as SACP.
On the basis of these models, we investigated a modification to perform cold SACP in an acute porcine model of hypothermic circulatory arrest. The results were compared with animals which underwent HCA without adjunctive cerebral perfusion.
| 2. Material and methods |
|---|
|
|
|---|
2.2. Anesthesia, perioperative management and neurophysiology
All animals received human care in compliance with the guidelines Principles of Laboratory Animal Care formulated by the National Society for Medical Research and the Guide for the Care and Use of Laboratory Animals published by the National Institute of Health (NIH Publication No. 88-23, revised 1996). The protocols for all experiments were approved by the Hannover Medical School Institutional Animal Care and Use Committee as well as the Land Niedersachsen.
After pre-treatment with intramuscular azaperone (5 mg/kg) and atropine (0.5 mg), animals were anesthesized with intravenous thiopental sodium (15 mg/kg). After endotracheal intubation, the pigs were mechanically ventilated with a FiO2 of 0.5 and isoflurane (12%). Continuous intravenous infusion of Fentanyl (1 µg kg1 h1) was administered to maintain adequate analgesia. Paralysis was achieved with intravenous pancuroniumbromide (0.1 mg/kg). The ventilator rate and the tidal volume were adjusted to maintain the arterial carbon dioxide tension between 35 and 45 mmHg. A positive endexpiratory pressure of 35 mmHg was frequently used. Before intervention, all animals received 1 g of Ceftriaxon intravenously.
A transurethral Foley bladder catheter (810 F) was inserted for online measurement of urine output and temperatures probes were placed in the rectum and the esophageous. The Picco® (Pulsion Medical Systems AG, Munich, Germany) catheter was placed in the right femoral artery for arterial pressure monitoring, blood sampling and to allow detection of cardiac output by thermodilution. For venous infusion as well as detection of central venous pressure, a 3-luminal catheter was advanced via the right femoral vein towards the right atrium. After midline incision on the pigs head, a small burr hole (0.7 cm diameter) was drilled in the skull to allow introduction of the intraparenchymal microtip pressure catheter (Codman ICP Express®, Johnson and Johnson Prof. Inc., Raynham, MA, USA) and the Neurotrend® probe (Codman, Johnson and Johnson Professional, Inc. Raynham, MA, USA), a device which incorporates optical sensors for the measurement of pH, pCO2, and pO2, and a thermocouple for temperature measurement. The Neurotrend® sensor indicates the perfusion and metabolic acidosis/alkalosis status of cerebral tissue local to sensor placement. The sensor is contained within a polyethylene tube with an average outside diameter of less than 0.5 mm and an effective sensor length of 25 mm. The catheter was placed slightly posterior to the coronal suture approximately 0.5 cm from the midline and was pushed 2 cm vertical into the white matter of the brain. The proper location has been tested in pilot studies and standardization was tried to achieve as much as possible.
Cervical and cortical somatosensory evoked potentials in response to stimulation of both median nerves as well as continuous EEG were monitored from needle electrodes which were placed in a standard fashion [6]. Analysis was performed by an investigator blinded to the protocol and are expressed as percent recovery compared to baseline measurements.
2.3. General surgical technique and cardiopulmonary bypass
After preparation of the skull and the groin, the animals were approached via a left thoracotomy in the 4th intercostal space. The pericardium was entered and the thymus removed to allow better access towards the supra-aortic vessels. After systemic heparinization (400 IU/kg), nonpulsatile cardiopulmonary bypass (CPB) was instituted at a flow rate of 70100 ml/kg via a right-angled 8F single cannula (Polystan, Denmark) in the main pulmonary artery, with return to the distal ascending aorta (Medtronic, 12F). A 10F flexible cannula was passed from the left appendage of the atrium into the left ventricle to allow decompression. Surface cooling was used in all animals, without additional topical cooling of the head. Priming of the pump consisted of 1000 ml 0.9%NaCl, furosemide (0.5 mg/kg), heparine (5000 IU) and potassium chloride (1 mVal/kg). For CPB, alpha-stat principles were used and the pressure was maintained at a minimum of 40 mmHg. Methylprednisolone (20 mg/kg body weight) was administered 15 min after initiation of CPB, but no barbiturates were given in the present model. Myocardial protection was achieved by repetitive administration of cold blood cardioplegia in the aortic root as well as topical cooling. After HCA, careful rewarming (avoiding a temperature gradient exceeding 8 °C between perfusate and core temperature) was continued to reach an esophageal temperature of approximately 36 °C. Internal defibrillation was performed after reaching a temperature of >27 °C and potassium <5.5 mmol/l. During weaning from CPB, catecholamines such as dobutamine or norepinehrine were frequently used for inotropic support or to treat vascular resistance vagaries.
2.4. Special considerations regarding selective antegrade cerebral perfusion
In contrast to the human anatomy, the pig has only two main vessels arising from the aortic arch. The first branch (brachiocephalic artery) is the source of both carotid arteries with the bifurcation in the apex of the left chest cavity (compare Fig. 1a)
. Prior to the bifurcation into both carotid arteries the left subclavian artery arises from behind the brachiocephalic artery.
|
2.5. Study protocol
Hemodynamics including ICP, blood gases, hematocrit as well as neurophysiological parameters (EEG, tissue O2, CO2 and pH) and temperatures were recorded online and analysed at the following time points.
| 3. Statistics |
|---|
|
|
|---|
| 4. Results |
|---|
|
|
|---|
A comparison of preoperative animal weights (SACP: 31.5±1.5 kg vs. HCA: 29.5±3.0 kg) and age (SACP: 13±3 weeks vs. HCA: 14±3weeks) showed no significant differences between the groups. Basic hemodynamic data showed some minor variations but no clinically relevant differences between groups in heart rate, central venous pressure, mean arterial pressure and cardiac output (Table 1) . Slight but not significant differences were observed concerning the upward drift of the intracranial temperature in the HCA group.
|
4.1. Neurophysiology
There was a marked increase in intracranial pressure in both groups two hours after reinstitution of the whole body reperfusion. After 4 h, the rise in ICP was significantly more pronounced in the HCA group (225% of baseline) than in the SACP group (130% of baseline, P<0.01). Over the last 3 h of the experiments, the differences between groups increased steadily towards higher levels in the HCA group (P>0.01) (Fig. 2) .
|
|
|
|
|
| 5. Discussion |
|---|
|
|
|---|
In the present study, we tested a new modification of an acute porcine model, which allows for SACP without the need of additional incisions or cannulas. In contrast to other studies, in which the whole upper body is perfused [13], the amount of blood reaching the brain can be defined by isolated perfusion of the bicarotid trunk. Furthermore chronic observations are possible since the number of incisions are limited and since a lateral thoracotomy is less traumatic than any median sternotomy in swine. Therefore a number of interesting questions concerning selective cerebral perfusion techniques could be answered in this model.
In our first series we were interested to study the effects of cold cerebral perfusion in contrast to HCA alone. Besides the impressive early recovery of neurophysiological parameters in the SACP group, we realized once again the meaningful impact of the intracranial pressure during reperfusion. It seems that in contrast to HCA alone, continuous cold selective cerebral perfusion can reduce the increase of ICP during whole body reperfusion. Although ICP was rising in both groups the levels continued to be significantly lower after SACP during the whole observation period.
In this context, Ehrlich and coworkers showed in 2001, that an interval of cold reperfusion after HCA can attenuate the rise in ICP usually seen after HCA, and can also reduce the amount of histopathological changes [14]. Furthermore studies of RCP have shown that RCP is often associated with a marked increase in ICP [12] and a worse neurological outcome. In a chronic porcine study published in 2002 we were able to show a close correlation between low ICPs during reperfusion and the occurance of EEG recovery [15]. Furthermore high ICP values during reperfusion correlated well with a worse neurobehavioral outcome. Unfortunately, we were not able to differentiate if high ICP values cause neurological damage or if it is just a reflection of incomplete cerebral protection.
In the present study we used a monitoring device for local tissue pH and CO2 with two modified optical fibers as well as detection of O2 using a Clark electrode, allowing estimation of acidosis and its respiratory or metabolic components. Monitoring of the trend allows early detection of acidemia, which may indicate compromised tissue perfusion. Since there are marked interindividual differences regarding absolute values, continuous monitoring of these parameters and analysis as change from baseline have to be performed and may help to identify and distinguish hypoxic and ischemic episodes. The proper function of the device has been tested in pilot experiments in which modifications of cerebral perfusion have been performed (data not shown). In the present study, animals which were subjected to HCA without cerebral perfusion, had significant higher tissue CO2 levels compared to those who had adjunctive ASCP. This was associated with a lower pH, indicating tissue acidosis. These phenomena could be observed even 4 hours after HCA. Interestingly, O2 levels were significantly higher in the early reperfusion period after HCA, indicating luxury perfusion after HCA. Nevertheless, this better perfusion did not reverse tissue acidosis and seemed to cause tissue edema indicated by high ICP pressures. The reasons for these findings remain speculative, but capillary leakage or insufficient capillary perfusion due to arterio-venoes shunting may be involved in the pathophysiological pathways.
| 6. Limitations |
|---|
|
|
|---|
| 7. Conclusions |
|---|
|
|
|---|
| Acknowledgments |
|---|
The authors want to thank Helmut Preissler from Preissler Medizintechnik GmbH, Augsburg, Germany, for providing the neurophysiological devices for EEG and SSEP analysis.
We would like to thank our research coordinators and technicians Astrid Diers-Ketterkatt, Petra Ziehme, Rosie Katt, Karin Peschel and Anja Giese for technical assistance and Kalle Napierski and Paul Zerbe for their care of the animals.
| Footnotes |
|---|
| Appendix A. Conference Discussion |
|---|
|
|
|---|
Dr Hagl: It is true, that our model is a pretty tough one. It has been originally described by the Mount Sinai group affiliated with Dr Griepp. They gained quite a lot of experience over the years and they were able to demonstrate that you need at least 7590 min of hypothermic circulatory arrest at 20 °C to produce some kind of cerebral damage in a porcine model. And even to detect these neurological changes you need sophisticated neurophysiological and histopathological techniques. But on the other hand you need to produce significant damage to detect potential benefits of different cerebral protection methods.
You are absolutely correct that the time frame is not really comparable with the clinical situation in human beings, which remains a limitation of our animal model. But we still believe that this model can give us further insight into the pathophysiolgy of hypothermic circulatory arrest and the effects of different potentially neuroprotective techniques.
Dr A. Corno (Lausanne, Switzerland): First of all, you should be congratulated for your effort to move the surgeons away from deep hypothermic circulatory arrest towards a more physiologic perfusion. Two questions. First, why did you use in your model of circulatory arrest the alpha-stat instead of the pH-stat, since there are several recent reports about better cerebral protection given by pH-stat in both experimental and clinical studies? Second question, if you want to go far from deep hypothermic circulatory arrest, why do you use cold antegrade cerebral perfusion instead of normothermic?
Dr Hagl: Concerning the first question you are right, there is some controversial discussion regarding the value of pH or alpha-stat in this setting. Actually, we have adjusted our model on our clinical situation in adults, where we exclusively use alpha-stat management. But there are a number of experimental and clinical reports in the literature, especially from the Boston group, who demonstrated positive effects of a pH-stat regime. This seems to be especially true in pediatric cardiac surgery. From the pathophysiological standpoint we know that pH-stat causes a breakdown of the autoregulation of the brain. This may be beneficial during cooling since you get more sustained and thorough cooling of the body and a more complete reduction of tissue metabolism. On the other hand during reperfusion you may increase intracranial pressure due to luxury perfusion and you also increase the embolic load. The solution may be using pH-stat during cooling and alpha-stat during reperfusion. But for this you need very experienced pump technicians and anesthesiologists to avoid confusion in the OR.
Dr Corno: The second question is, if you want to move more towards better physiological perfusion, why are you still using cold perfusion instead of warm?
Dr Hagl: That is a good question. Actually, we do not know what is the ideal temperature for cerebral perfusion and at what temperature can we stop the pump without doing harm to our patients. If you look in the literature, you will realize that there are a number of different concepts, but most of them are empirical. If you asked Dr Schepens, who is also in the audience, he will tell you that you can use relatively warm cerebral perfusion and the results of his clinical studies are really favourable and seem to support this thesis.
We strongly feel, that our model may offer the opportunity to study exactly these important questions. May be, I can answer some of your questions in the next year.
Did you plan to harvest the brain to measure the extent of neuronal apoptosis and necrosis and caspases activation in that model?
Dr Hagl: Yes, actually we did that. But we are still fighting the problem that standard histopathology did not show any differences in the brains after four hours. Even with sophisticated apoptosis staining, and we did that in these brains, it is not that easy to find any differences. Due to these disappointing results we look now for something like heat shock protein, which has been shown to be involved in the pathophysiology of brain ischemia and which seems to be good marker even four hours after circulatory arrest.
Mr Lang-Lazdunski: Actually, MAP-2 immunohistochemistry is an excellent technique because even after 3 h you can see the damage in the brain.
Dr Hagl: Thanks for this comment. Actually, we have no experience with this marker, but I am eager to learn more about it. I would appreciate if we can discuss the issue further after the session.
Dr J. Bachet (Paris, France): This beautiful scientific study demonstrates what we intuitively assumed when we published 15 years ago the technique of cold blood cerebral perfusion.
If I remember well, all your pigs were put in general deep hypothermia. You are aware that the advantage of selective cerebral perfusion is, first, to implement the only way to correctly protect the brain during arch exclusion, but secondly, to get rid of all the drawbacks of deep hypothermia.
My question is: do you think that you could do the same experiment with selectively perfusing the brain in moderate hypothermia of the whole body, and do you think that you could find exactly the same results, or even better results?
Dr Hagl: Actually, I cannot tell you if we may find better results. I would speculate, that there is a difference in one or the other way, because we know that activation of the inflammatory system also depends on temperature.
But there also may be another problem in this setting. As Dr Ueda mentioned before, 100 min of no flow perfusion in the lower body at 25 or even 28 °C, is quite a long time for no perfusion. You may get significant activation of acute phase reactants, causing hemodynamic instability, extravasation of protein and fluids, pulmonary edema and other problems. But as I mentioned before, we are open for all kind of suggestions and we may incorporate your idea in our next study.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
N. Khaladj, M. Shrestha, S. Meck, S. Peterss, H. Kamiya, K. Kallenbach, M. Winterhalter, L. Hoy, A. Haverich, and C. Hagl Hypothermic circulatory arrest with selective antegrade cerebral perfusion in ascending aortic and aortic arch surgery: A risk factor analysis for adverse outcome in 501 patients. J. Thorac. Cardiovasc. Surg., April 1, 2008; 135(4): 908 - 914. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Pretre and M. I. Turina Deep Hypothermic Circulatory Arrest Card. Surg. Adult, January 1, 2008; 3(2008): 431 - 442. [Full Text] |
||||
![]() |
S. Dahlbacka, H. Alaoja, J. Makela, E. Niemela, P. Laurila, K. Kiviluoma, A. Honkanen, P. Ohtonen, V. Anttila, and T. Juvonen Effects of pH Management During Selective Antegrade Cerebral Perfusion on Cerebral Microcirculation and Metabolism: Alpha-Stat Versus pH-Stat Ann. Thorac. Surg., September 1, 2007; 84(3): 847 - 855. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. K. Harrington, F. Fragomeni, and R. S. Bonser Cerebral Perfusion Ann. Thorac. Surg., February 1, 2007; 83(2): S799 - S804. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Khaladj, A. Haverich, and C. Hagl Reply to Ates and Gullu: Hypothermic circulatory arrest with selective antegrade cerebral perfusion: Is this the answer for optimal brain and body protection? Eur. J. Cardiothorac. Surg., January 1, 2007; 31(1): 139 - 139. [Full Text] [PDF] |
||||
![]() |
N. Khaladj, S. Peterss, P. Oetjen, R. von Wasielewski, G. Hauschild, M. Karck, A. Haverich, and C. Hagl Hypothermic circulatory arrest with moderate, deep or profound hypothermic selective antegrade cerebral perfusion: which temperature provides best brain protection? Eur. J. Cardiothorac. Surg., September 1, 2006; 30(3): 492 - 498. [Abstract] [Full Text] [PDF] |
||||
![]() |
Antegrade cerebral perfusion reduces apoptotic neuronal injury in a neonatal piglet model of cardiopulmonary bypass. J. Thorac. Cardiovasc. Surg., March 1, 2006; 131(3): 659 - 665. |
||||
![]() |
J. Barnard, J. Dunning, M. Grossebner, and M. N. Bittar In aortic arch surgery is there any benefit in using antegrade cerebral perfusion or retrograde cerebral perfusion as an adjunct to hypothermic circulatory arrest? Interactive CardioVascular and Thoracic Surgery, December 1, 2004; 3(4): 621 - 630. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |